Brief: Landos Biopharma Provides Comprehensive Update On Clinical Development Plans

Landos Biopharma

05/01/2023 12:08

Jan 5 (Reuters) - Landos Biopharma Inc  LABP.O :
    * LANDOS BIOPHARMA PROVIDES COMPREHENSIVE UPDATE ON CLINICAL
DEVELOPMENT PLANS
    * LANDOS BIOPHARMA INC - ADVANCING NX-13 CLINICAL
DEVELOPMENT FOR
TREATMENT OF ULCERATIVE COLITIS
    * LANDOS BIOPHARMA INC - ON TRACK TO INITIATE PHASE 2
PROOF-OF-CONCEPT TRIAL FOR NX-13 IN Q2 OF 2023 AND REPORT
TOPLINE DATA BY Q4 OF 2024
    * LANDOS BIOPHARMA INC - EXPECTS TO HAVE SUFFICIENT CASH,
CASH
EQUIVALENTS AND MARKETABLE SECURITIES TO FUND PLANNED OPERATIONS
INTO H1 OF 2025

Source text for Eikon:  ID:nGNX2tQbq5 
Further company coverage:  LABP.O 
 ((Reuters.Briefs@thomsonreuters.com;))